Fixed Versus Variable Dosing of Prothrombin Complex Concentrate in Vitamin K Antagonist-Related Intracranial Hemorrhage: A Retrospective Analysis

被引：0
|
作者：
Rahat Amadkhan Abdoellakhan
Ishita Parveen Miah
Nakisa Khorsand
Karina Meijer
Korné Jellema
机构：
[1] University Medical Center Groningen,Department of Haematology
[2] Apotheek Haagse Ziekenhuizen,Department of Pharmacy
[3] Medical Center Haaglanden,Department of Neurology
来源：
Neurocritical Care | 2017年 / 26卷
关键词：
Intracranial hemorrhage; Hemostasis; International normalized ratio; Prothrombin complex concentrate; Vitamin K antagonist;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：64 / 69
页数：5
相关论文
共 50 条
  • [31] Fixed-Dose Four-Factor Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal: Does One Dose Fit All?
    Schwebach, Alyson A.
    Waybright, Ryan A.
    Johnson, Thomas J.
    PHARMACOTHERAPY, 2019, 39 (05): : 599 - 608
  • [32] Four-Factor Prothrombin Complex Concentrate Versus Plasma for Urgent Vitamin K Antagonist Reversal New Evidence
    Sarode, Ravi
    CLINICS IN LABORATORY MEDICINE, 2014, 34 (03) : 613 - +
  • [33] Bedside Catheter Hematoma Evacuation in Vitamin K Antagonist-Related Intracerebral Hemorrhage: A Safe and Feasible Approach
    Volbers, Bastian
    Niesen, Wolf-Dirk
    Amiri-Soltani, Samuel
    Staykov, Dimitre
    Shah, Mukesch Johannes
    Lang, Stefan
    Luecking, Hannes
    Kuramatsu, Joji B.
    Huttner, Hagen B.
    Schwab, Stefan
    Bardutzky, Juergen
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [34] Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication
    Yasaka, M
    Sakata, T
    Minematsu, K
    Naritomi, H
    THROMBOSIS RESEARCH, 2002, 108 (01) : 25 - 30
  • [35] Safety and effectiveness of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal following a fixed-dose strategy
    Sobrino Jimenez, Carmen
    Antonio Romero-Garrido, Jose
    Garcia-Martin, Angeles
    Quintana-Diaz, Manuel
    Jimenez-Vicente, Carlos
    Gonzalez-Del Valle, Luis
    Ambrosio, Alicia Herrero
    Benedi-Gonzalez, Juana
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021, 28 (E1) : E66 - E71
  • [36] Retrospective evaluation of the clinical use of prothrombin complex concentrate for the reversal of anticoagulation with vitamin K antagonists
    Cruz, Jennifer L.
    Moss, Mary C.
    Chen, Sheh-Li
    Hansen, Kayla M.
    Amerine, Lindsey B.
    BLOOD COAGULATION & FIBRINOLYSIS, 2015, 26 (04) : 378 - 382
  • [37] Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation
    Tanaka, Kenichi A.
    Szlam, Fania
    Dickneite, Gerhard
    Levy, Jerrold H.
    THROMBOSIS RESEARCH, 2008, 122 (01) : 117 - 123
  • [38] Evaluation of fixed-dose versus variable-dose prothrombin complex concentrate for warfarin reversal
    Bajdas, Haley
    Handzel, Michele
    Uttaro, Elizabeth
    Jones, Courtney M. C.
    Kokanovich, Kate
    Acquisto, Nicole M.
    THROMBOSIS RESEARCH, 2022, 214 : 76 - 81
  • [39] A low fixed dose of prothrombin complex concentrate is cost effective in emergency reversal of vitamin K antagonists
    Khorsand, Nakisa
    Giepmans, Lisette
    Meijer, Karina
    van Hest, Reinier M.
    Veeger, Nic J. G. M.
    HAEMATOLOGICA, 2013, 98 (06) : E65 - E67
  • [40] Andexanet alfa effectiveness and safety versus four-factor prothrombin complex concentrate (4F-PCC) in intracranial hemorrhage while on apixaban or rivaroxaban: A single-center, retrospective, matched cohort analysis
    Parsels, Katie A.
    Seabury, Robert W.
    Zyck, Stephanie
    Miller, Christopher D.
    Krishnamurthy, Satish
    Darko, William
    Probst, Luke A.
    Latorre, Julius Gene
    Cwikla, Gregory M.
    Feldman, Elizabeth A.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 55 : 16 - 19
12345